What is Jagsonpal Pharmaceuticals Ltd.'s official website?

Jagsonpal Pharmaceuticals Ltd.'s website is http://www.jagsonpal.com

How many employees are working in Jagsonpal Pharmaceuticals Ltd. right now?

Jagsonpal Pharmaceuticals Ltd. has 859 employees.

What is Jagsonpal Pharmaceuticals Ltd.'s industry?

Jagsonpal Pharmaceuticals Ltd.'s industry is Pharmaceutical Manufacturing

Who are Jagsonpal Pharmaceuticals Ltd.'s top competitors?

Jagsonpal Pharmaceuticals Ltd.'s top competitors are , , , , , ,

Jagsonpal Pharmaceuticals Ltd. company information, Employees & Contact Information

Explore related pages

Jagsonpal Pharmaceuticals Ltd. email format Jagsonpal Pharmaceuticals Ltd. management contacts

Related company profiles:

Founded in 1978, Jagsonpal has emerged as an organisation of trust and credibility among the medical fraternity. What started as a humble chemist store in Delhi is now a small yet meaningful player in core therapies of Gynaecology and Orthopaedic which together account for over 90% business

Employees: 859
Founded: -
Address: Nimai Towers, 3rd Floor,412-415,udyog Vihar Phase 4,india
Industry: Pharmaceutical Manufacturing
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

In-Vitro Diagnostic Substance Manufacturing

Biological Product (except Diagnostic) Manufacturing
Website: http://www.jagsonpal.com
Keywords: substantial research and development, manufacturing, marketing and distribution facilities, finished formulations, and Gynaecology, Orthopaedics & General Speciality.
HQ: Gurugram, Haryana
Competitors: Wings Pharmaceuticals Pvt. Ltd., MANKIND PHARMA LTD, Obsurge Biotech Ltd., Akums Drugs& Pharmaceuticals Ltd, Gracure Pharmaceuticals Ltd., Seagull Pharma, Rapross Pharmaceuticals Private Limited, Salve Pharmaceuticals Pvt Ltd, Arbro Pharmaceuticals Private Ltd., Kee Pharma Ltd.

Jagsonpal Pharmaceuticals Ltd. Questions

News

We Take A Look At Why Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) CEO Compensation Is Well Earned - simplywall.st

We Take A Look At Why Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) CEO Compensation Is Well Earned simplywall.st

Jagsonpal Pharmaceuticals appoints Amrut Medhekar as Chief Operating Officer - Indian Pharma Post

Jagsonpal Pharmaceuticals appoints Amrut Medhekar as Chief Operating Officer Indian Pharma Post

USFDA pulls up Jagsonpal Pharmaceuticals for manufacturing lapses at API plant - The Economic Times

USFDA pulls up Jagsonpal Pharmaceuticals for manufacturing lapses at API plant The Economic Times

Jagsonpal Pharmaceuticals allots 93,445 equity shares under ESOP - Business Standard

Jagsonpal Pharmaceuticals allots 93,445 equity shares under ESOP Business Standard

Market Might Still Lack Some Conviction On Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) Even After 33% Share Price Boost - simplywall.st

Market Might Still Lack Some Conviction On Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) Even After 33% Share Price Boost simplywall.st

Jagsonpal Pharmaceuticals posts Q4 FY25 PAT at Rs. 6.58 Cr - Indian Pharma Post

Jagsonpal Pharmaceuticals posts Q4 FY25 PAT at Rs. 6.58 Cr Indian Pharma Post

Jagsonpal Pharmaceuticals 1:2.5 stock split record date tomorrow. Do you own? - The Economic Times

Jagsonpal Pharmaceuticals 1:2.5 stock split record date tomorrow. Do you own? The Economic Times

Jagsonpal Pharmaceuticals Q1 FY26 revenue up 23.1% - Indian Pharma Post

Jagsonpal Pharmaceuticals Q1 FY26 revenue up 23.1% Indian Pharma Post

Jagsonpal Pharma shares jump 10% after stellar Q3 results; know more - Business Standard

Jagsonpal Pharma shares jump 10% after stellar Q3 results; know more Business Standard

Jagsonpal Pharmaceuticals Hits Day Low Amid Price Pressure, Drops to Rs 213.25 - Markets Mojo

Jagsonpal Pharmaceuticals Hits Day Low Amid Price Pressure, Drops to Rs 213.25 Markets Mojo

Jagsonpal Pharmaceuticals Appoints Amrut Medhekar as Chief Operating Officer - scanx.trade

Jagsonpal Pharmaceuticals Appoints Amrut Medhekar as Chief Operating Officer scanx.trade

Jagsonpal Pharmaceuticals record date for 1:2.5 stock split today - The Economic Times

Jagsonpal Pharmaceuticals record date for 1:2.5 stock split today The Economic Times

Stocks to Watch, Feb 24: Britannia, BPCL, Mannapuram Fin, HCG, Jagsonpal - Business Standard

Stocks to Watch, Feb 24: Britannia, BPCL, Mannapuram Fin, HCG, Jagsonpal Business Standard

Jagsonpal Pharmaceuticals appoints Sachin Jain as CFO - Indian Pharma Post

Jagsonpal Pharmaceuticals appoints Sachin Jain as CFO Indian Pharma Post

Private equity firms are Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) biggest owners and were hit after market cap dropped ₹1.8b - simplywall.st

Private equity firms are Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) biggest owners and were hit after market cap dropped ₹1.8b simplywall.st

Jagsonpal Pharma appoints Nirav Vora as CFO - Business Standard

Jagsonpal Pharma appoints Nirav Vora as CFO Business Standard

Briefs: Jagsonpal Pharmaceuticals, Dr. Reddy’s Laboratories and Akums Drugs and Pharmaceuticals - Indian Pharma Post

Briefs: Jagsonpal Pharmaceuticals, Dr. Reddy’s Laboratories and Akums Drugs and Pharmaceuticals Indian Pharma Post

Jagsonpal Pharma gains after reporting strong Q3 numbers - Business Standard

Jagsonpal Pharma gains after reporting strong Q3 numbers Business Standard

Jagsonpal Pharmaceuticals launches QueeZy-ER - Indian Pharma Post

Jagsonpal Pharmaceuticals launches QueeZy-ER Indian Pharma Post

Infinity Holding Group to acquire 43.7 per cent stake in Jagsonpal Pharma - Indian Pharma Post

Infinity Holding Group to acquire 43.7 per cent stake in Jagsonpal Pharma Indian Pharma Post

Jagsonpal Pharmaceuticals standalone net profit rises 102.63% in the June 2025 quarter - Business Standard

Jagsonpal Pharmaceuticals standalone net profit rises 102.63% in the June 2025 quarter Business Standard

Jagsonpal Pharma up 7% as co to consider Q2 results, stock-split on Oct 23 - Business Standard

Jagsonpal Pharma up 7% as co to consider Q2 results, stock-split on Oct 23 Business Standard

Jagsonpal Pharmaceuticals acquires Yash Pharma's India, Bhutan business - ET HealthWorld

Jagsonpal Pharmaceuticals acquires Yash Pharma's India, Bhutan business ET HealthWorld

Stock Alert: Advait Energy Transitions, Jagsonpal Pharmaceuticals, Container Corp, IFGL Refractories - Business Standard

Stock Alert: Advait Energy Transitions, Jagsonpal Pharmaceuticals, Container Corp, IFGL Refractories Business Standard

Jagsonpal Pharmaceuticals Q1 FY25 revenues at Rs. 61.4 Crores, 41% growth over Q4 FY24 - Indian Pharma Post

Jagsonpal Pharmaceuticals Q1 FY25 revenues at Rs. 61.4 Crores, 41% growth over Q4 FY24 Indian Pharma Post

Sebi Bans 2 Individuals in Jagsonpal Pharma Insider Trading Case - Rediff MoneyWiz

Sebi Bans 2 Individuals in Jagsonpal Pharma Insider Trading Case Rediff MoneyWiz

Jagsonpal Pharma introduces new product; shares rise - BusinessLine

Jagsonpal Pharma introduces new product; shares rise BusinessLine

Jagsonpal Pharmaceuticals Outperforms Sector Amid Broader Market Challenges - Markets Mojo

Jagsonpal Pharmaceuticals Outperforms Sector Amid Broader Market Challenges Markets Mojo

Jagsonpal Pharmaceuticals standalone net profit rises 85.35% in the March 2025 quarter - Business Standard

Jagsonpal Pharmaceuticals standalone net profit rises 85.35% in the March 2025 quarter Business Standard

Sebi bans 2 individuals from securities markets for 1 year in Jagsonpal Pharma insider trading case - Press Trust of India

Sebi bans 2 individuals from securities markets for 1 year in Jagsonpal Pharma insider trading case Press Trust of India

Jagsonpal Pharmaceuticals Ltd Q1 FY2025-26 net profit climbs to Rs. 10.79 crores - EquityBulls

Jagsonpal Pharmaceuticals Ltd Q1 FY2025-26 net profit climbs to Rs. 10.79 crores EquityBulls

Jagsonpal Finance to Acquire Welcast Finstocks, Plans Name Change to Jagsonpal Services - scanx.trade

Jagsonpal Finance to Acquire Welcast Finstocks, Plans Name Change to Jagsonpal Services scanx.trade

Jagsonpal Pharmaceuticals allots 66,000 equity shares under ESOP - Business Standard

Jagsonpal Pharmaceuticals allots 66,000 equity shares under ESOP Business Standard

Convergent Finance to acquire controlling stake in Jagsonpal Pharmaceuticals - Express Pharma

Convergent Finance to acquire controlling stake in Jagsonpal Pharmaceuticals Express Pharma

Jagsonpal Pharmaceuticals Strengthens Market Footing with Yash Pharma Acquisition - ThePrint

Jagsonpal Pharmaceuticals Strengthens Market Footing with Yash Pharma Acquisition ThePrint

Jagsonpal Pharmaceuticals appoints Manish Gupta as the MD - Indian Pharma Post

Jagsonpal Pharmaceuticals appoints Manish Gupta as the MD Indian Pharma Post

Sebi Imposes One-Year Ban on Two Individuals for Insider Trading in Jagsonpal Pharmaceuticals - Goodreturns

Sebi Imposes One-Year Ban on Two Individuals for Insider Trading in Jagsonpal Pharmaceuticals Goodreturns

Medical Representative- PUNE / Hyderabad - Siasat.com

Medical Representative- PUNE / Hyderabad Siasat.com

Jagsonpal Pharmaceuticals trades jubilantly on entering into agreement with Suvinys Developers - Udaipur Kiran

Jagsonpal Pharmaceuticals trades jubilantly on entering into agreement with Suvinys Developers Udaipur Kiran

Companies like Jagsonpal Pharmaceuticals Ltd.

Top Jagsonpal Pharmaceuticals Ltd. Employees

Amit Saxena

Digital Marketing Specialist | Mba In…

South Delhi, Delhi, India, India

View

1
gmail.com
Narindra Singh

Dgm -Sales At Jagsonpal Pharmaceuticals…

South Delhi, Delhi, India, India

View

1
rediffmail.com
Prithi S Kochhar

Ceo Naari Pharma| Inventor - Navad Life…

N/a

View
Satish Kesare

Marketing Head | Strategic Marketing |…

Mumbai, Maharashtra, India, India

View

2
gmail.com, fdcindia.com

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Jagsonpal Pharmaceuticals Ltd. company information, Employees & Contact Information

Explore related pages

Company Details

Jagsonpal Pharmaceuticals Ltd. Questions

What is Jagsonpal Pharmaceuticals Ltd.'s official website?

What is Jagsonpal Pharmaceuticals Ltd.'s LinkedIn profile?

How many employees are working in Jagsonpal Pharmaceuticals Ltd. right now?

What is Jagsonpal Pharmaceuticals Ltd.'s industry?

What are Jagsonpal Pharmaceuticals Ltd.'s top competitors?

What are Jagsonpal Pharmaceuticals Ltd.'s categories?

When was Jagsonpal Pharmaceuticals Ltd. founded?

News

We Take A Look At Why Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) CEO Compensation Is Well Earned - simplywall.st

Jagsonpal Pharmaceuticals appoints Amrut Medhekar as Chief Operating Officer - Indian Pharma Post

USFDA pulls up Jagsonpal Pharmaceuticals for manufacturing lapses at API plant - The Economic Times

Jagsonpal Pharmaceuticals allots 93,445 equity shares under ESOP - Business Standard

Market Might Still Lack Some Conviction On Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) Even After 33% Share Price Boost - simplywall.st

Jagsonpal Pharmaceuticals posts Q4 FY25 PAT at Rs. 6.58 Cr - Indian Pharma Post

Jagsonpal Pharmaceuticals 1:2.5 stock split record date tomorrow. Do you own? - The Economic Times

Jagsonpal Pharmaceuticals Q1 FY26 revenue up 23.1% - Indian Pharma Post

Jagsonpal Pharma shares jump 10% after stellar Q3 results; know more - Business Standard

Jagsonpal Pharmaceuticals Hits Day Low Amid Price Pressure, Drops to Rs 213.25 - Markets Mojo

Jagsonpal Pharmaceuticals Appoints Amrut Medhekar as Chief Operating Officer - scanx.trade

Jagsonpal Pharmaceuticals record date for 1:2.5 stock split today - The Economic Times

Stocks to Watch, Feb 24: Britannia, BPCL, Mannapuram Fin, HCG, Jagsonpal - Business Standard

Jagsonpal Pharmaceuticals appoints Sachin Jain as CFO - Indian Pharma Post

Private equity firms are Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) biggest owners and were hit after market cap dropped ₹1.8b - simplywall.st

Jagsonpal Pharma appoints Nirav Vora as CFO - Business Standard

Briefs: Jagsonpal Pharmaceuticals, Dr. Reddy’s Laboratories and Akums Drugs and Pharmaceuticals - Indian Pharma Post

Jagsonpal Pharma gains after reporting strong Q3 numbers - Business Standard

Jagsonpal Pharmaceuticals launches QueeZy-ER - Indian Pharma Post

Infinity Holding Group to acquire 43.7 per cent stake in Jagsonpal Pharma - Indian Pharma Post

Jagsonpal Pharmaceuticals standalone net profit rises 102.63% in the June 2025 quarter - Business Standard

Jagsonpal Pharma up 7% as co to consider Q2 results, stock-split on Oct 23 - Business Standard

Jagsonpal Pharmaceuticals acquires Yash Pharma's India, Bhutan business - ET HealthWorld

Stock Alert: Advait Energy Transitions, Jagsonpal Pharmaceuticals, Container Corp, IFGL Refractories - Business Standard

Jagsonpal Pharmaceuticals Q1 FY25 revenues at Rs. 61.4 Crores, 41% growth over Q4 FY24 - Indian Pharma Post

Sebi Bans 2 Individuals in Jagsonpal Pharma Insider Trading Case - Rediff MoneyWiz

Jagsonpal Pharma introduces new product; shares rise - BusinessLine

Jagsonpal Pharmaceuticals Outperforms Sector Amid Broader Market Challenges - Markets Mojo

Jagsonpal Pharmaceuticals standalone net profit rises 85.35% in the March 2025 quarter - Business Standard

Sebi bans 2 individuals from securities markets for 1 year in Jagsonpal Pharma insider trading case - Press Trust of India

Jagsonpal Pharmaceuticals Ltd Q1 FY2025-26 net profit climbs to Rs. 10.79 crores - EquityBulls

Jagsonpal Finance to Acquire Welcast Finstocks, Plans Name Change to Jagsonpal Services - scanx.trade

Jagsonpal Pharmaceuticals allots 66,000 equity shares under ESOP - Business Standard

Convergent Finance to acquire controlling stake in Jagsonpal Pharmaceuticals - Express Pharma

Jagsonpal Pharmaceuticals Strengthens Market Footing with Yash Pharma Acquisition - ThePrint

Jagsonpal Pharmaceuticals appoints Manish Gupta as the MD - Indian Pharma Post

Sebi Imposes One-Year Ban on Two Individuals for Insider Trading in Jagsonpal Pharmaceuticals - Goodreturns

Medical Representative- PUNE / Hyderabad - Siasat.com

Jagsonpal Pharmaceuticals trades jubilantly on entering into agreement with Suvinys Developers - Udaipur Kiran

Companies like Jagsonpal Pharmaceuticals Ltd.

Salve Pharmaceutical...

Gracure Pharmaceutic...

Akums Drugs& Pharmac...

Arbro Pharmaceutical...

Kee Pharma Ltd

Wings Pharmaceutical...

Obsurge Biotech Ltd.

Rapross Pharmaceutic...

Mankind Pharma Ltd

Seagull Pharma

Top Jagsonpal Pharmaceuticals Ltd. Employees

Amit Saxena

Digital Marketing Specialist | Mba In…

Narindra Singh

Dgm -Sales At Jagsonpal Pharmaceuticals…

Prithi S Kochhar

Ceo Naari Pharma| Inventor - Navad Life…

Satish Kesare

Marketing Head | Strategic Marketing |…

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data